INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 460m ago
House PTR59m ago
SEC 13F59m ago
Robinhood Chain59m ago

Results

76,369 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
26 sh
Jun 25, 2026Jun 29, 2026
Page 754 of 1910
← PrevNext →
traded Jun 25, 2026
+4d
SEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
152 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
252 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
VE
Vanderjagt Katherine E.VP & Chief HR Officer
LZBLA-Z-BOY INC
Tax withholding
F$22K
534 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
RS
Renda Frankie S.Director, PRESIDENT AND CEO, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
55.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
73 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
55 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LY
Lee Carol YoungVP & Chief Information Officer
LZBLA-Z-BOY INC
Tax withholding
F$14K
342 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
CB
Cooperstone BrendaDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
24 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
GD
Goldberg Andrew D.Director
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
3,837 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LL
Lawver Teri LSVP & Chief Commercial Officer
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
90.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
VE
Vanderjagt Katherine E.VP & Chief HR Officer
LZBLA-Z-BOY INC
Tax withholding
F$12K
283 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

9
RV
Renda Rudolph V.Director, CO-COO AND EVP, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
15.7K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
WA
Walia AshokChief Financial Officer
FUNSix Flags Entertainment Corporation/NEW
Grant or award
A—
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
KG
Kirkland Derek GDirector
JXNJackson Financial Inc.
Grant or award
A—
125 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
GD
Goldberg Andrew D.Director
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
2,417 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
SR
Sundy Robert IIPresident, Retail
LZBLA-Z-BOY INC
Tax withholding
F$12K
296 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
4 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CS
Campbell ShannonDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
40.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
96 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
40.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
CE
Crowley ElizabethSR. VP & CPDO
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
VT
Van Hauwermeiren TimothyDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
23 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
49 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CS
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
95.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LJ
Lippert Martin JDirector
JXNJackson Financial Inc.
Grant or award
A—
399 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LE
Luebke Taylor EdwardSVP and CFO
LZBLA-Z-BOY INC
Tax withholding
F$8,763
214 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
AK
Agger Mette KirstineDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$63K
500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
64 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
NG
Noles Russell GDirector
JXNJackson Financial Inc.
Grant or award
A—
189 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Craig Kevin WDirector
FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/
Grant or award
A$11K
174 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

9
HM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
95.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence